Open Actively Recruiting

CorEvitas Generalized Pustular Psoriasis (GPP) Drug Safety and Effectiveness Registry

About

Brief Summary

This study has not yet been registered on ClinicalTrials.gov, which is currently a pre-requisite for display of detailed eligibility criteria.

Eligibility

Minimum Age
N/A
Maximum Age
N/A
Study Stats
Protocol No.
25-0637
Category
Genetic and Rare Diseases
Principal Investigator
April W. Armstrong, MD, MPH
April W. Armstrong, MD, MPH
Dermatology
April W. Armstrong, MD, MPH
Contact
  • Yvonne Nong
  • Hamida Askaryar
Location
  • UCLA Santa Monica
  • UCLA Westwood